339 related articles for article (PubMed ID: 10550301)
1. Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death.
Stadelmann C; Deckwerth TL; Srinivasan A; Bancher C; Brück W; Jellinger K; Lassmann H
Am J Pathol; 1999 Nov; 155(5):1459-66. PubMed ID: 10550301
[TBL] [Abstract][Full Text] [Related]
2. Caspase-cleaved amyloid precursor protein and activated caspase-3 are co-localized in the granules of granulovacuolar degeneration in Alzheimer's disease and Down's syndrome brain.
Su JH; Kesslak JP; Head E; Cotman CW
Acta Neuropathol; 2002 Jul; 104(1):1-6. PubMed ID: 12070657
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of cell death in neurodegenerative disorders.
Jellinger KA; Stadelmann C
J Neural Transm Suppl; 2000; 59():95-114. PubMed ID: 10961423
[TBL] [Abstract][Full Text] [Related]
4. The enigma of cell death in neurodegenerative disorders.
Jellinger KA; Stadelmann CH
J Neural Transm Suppl; 2000; (60):21-36. PubMed ID: 11205141
[TBL] [Abstract][Full Text] [Related]
5. Problems of cell death in neurodegeneration and Alzheimer's Disease.
Jellinger KA; Stadelmann C
J Alzheimers Dis; 2001 Feb; 3(1):31-40. PubMed ID: 12214070
[TBL] [Abstract][Full Text] [Related]
6. Apoptotic signals within the basal forebrain cholinergic neurons in Alzheimer's disease.
Wu CK; Thal L; Pizzo D; Hansen L; Masliah E; Geula C
Exp Neurol; 2005 Oct; 195(2):484-96. PubMed ID: 16085017
[TBL] [Abstract][Full Text] [Related]
7. ets-2 promotes the activation of a mitochondrial death pathway in Down's syndrome neurons.
Helguera P; Pelsman A; Pigino G; Wolvetang E; Head E; Busciglio J
J Neurosci; 2005 Mar; 25(9):2295-303. PubMed ID: 15745955
[TBL] [Abstract][Full Text] [Related]
8. Relation of hippocampal phospho-SAPK/JNK granules in Alzheimer's disease and tauopathies to granulovacuolar degeneration bodies.
Lagalwar S; Berry RW; Binder LI
Acta Neuropathol; 2007 Jan; 113(1):63-73. PubMed ID: 17089132
[TBL] [Abstract][Full Text] [Related]
9. In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease.
Selznick LA; Holtzman DM; Han BH; Gökden M; Srinivasan AN; Johnson EM; Roth KA
J Neuropathol Exp Neurol; 1999 Sep; 58(9):1020-6. PubMed ID: 10499444
[TBL] [Abstract][Full Text] [Related]
10. Activation of caspase-8 in the Alzheimer's disease brain.
Rohn TT; Head E; Nesse WH; Cotman CW; Cribbs DH
Neurobiol Dis; 2001 Dec; 8(6):1006-16. PubMed ID: 11741396
[TBL] [Abstract][Full Text] [Related]
11. Neuronal apoptosis and autophagy cross talk in aging PS/APP mice, a model of Alzheimer's disease.
Yang DS; Kumar A; Stavrides P; Peterson J; Peterhoff CM; Pawlik M; Levy E; Cataldo AM; Nixon RA
Am J Pathol; 2008 Sep; 173(3):665-81. PubMed ID: 18688038
[TBL] [Abstract][Full Text] [Related]
12. Correlation between caspase activation and neurofibrillary tangle formation in Alzheimer's disease.
Rohn TT; Head E; Su JH; Anderson AJ; Bahr BA; Cotman CW; Cribbs DH
Am J Pathol; 2001 Jan; 158(1):189-98. PubMed ID: 11141492
[TBL] [Abstract][Full Text] [Related]
13. DNA damage and activated caspase-3 expression in neurons and astrocytes: evidence for apoptosis in frontotemporal dementia.
Su JH; Nichol KE; Sitch T; Sheu P; Chubb C; Miller BL; Tomaselli KJ; Kim RC; Cotman CW
Exp Neurol; 2000 May; 163(1):9-19. PubMed ID: 10785439
[TBL] [Abstract][Full Text] [Related]
14. The carbonic anhydrase inhibitor methazolamide prevents amyloid beta-induced mitochondrial dysfunction and caspase activation protecting neuronal and glial cells in vitro and in the mouse brain.
Fossati S; Giannoni P; Solesio ME; Cocklin SL; Cabrera E; Ghiso J; Rostagno A
Neurobiol Dis; 2016 Feb; 86():29-40. PubMed ID: 26581638
[TBL] [Abstract][Full Text] [Related]
15. Evidence for caspase-mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease.
Chan SL; Griffin WS; Mattson MP
J Neurosci Res; 1999 Aug; 57(3):315-23. PubMed ID: 10412022
[TBL] [Abstract][Full Text] [Related]
16. Abortive apoptosis in Alzheimer's disease.
Raina AK; Hochman A; Zhu X; Rottkamp CA; Nunomura A; Siedlak SL; Boux H; Castellani RJ; Perry G; Smith MA
Acta Neuropathol; 2001 Apr; 101(4):305-10. PubMed ID: 11355301
[TBL] [Abstract][Full Text] [Related]
17. Caspase activation in the limbic cortex of subjects with early Alzheimer's disease.
Gastard MC; Troncoso JC; Koliatsos VE
Ann Neurol; 2003 Sep; 54(3):393-8. PubMed ID: 12953274
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38 kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies.
Ferrer I; Blanco R; Carmona M; Puig B
J Neural Transm (Vienna); 2001; 108(12):1397-415. PubMed ID: 11810404
[TBL] [Abstract][Full Text] [Related]
19. The active form of glycogen synthase kinase-3beta is associated with granulovacuolar degeneration in neurons in Alzheimer's disease.
Leroy K; Boutajangout A; Authelet M; Woodgett JR; Anderton BH; Brion JP
Acta Neuropathol; 2002 Feb; 103(2):91-9. PubMed ID: 11810173
[TBL] [Abstract][Full Text] [Related]
20. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
